<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02773589</url>
  </required_header>
  <id_info>
    <org_study_id>5368</org_study_id>
    <nct_id>NCT02773589</nct_id>
  </id_info>
  <brief_title>Prospective Evaluation of a New Approach to Perform an Esophageal Myotomy: the Transesophageal Submucosa Approach</brief_title>
  <official_title>Prospective Evaluation of a New Approach to Perform an Esophageal Myotomy: the Transesophageal Submucosa Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Achalasia is an esophagus motor disability characterized by a lack of relaxation of the lower&#xD;
      esophageal sphincter (LES) to deglutition. Myotomy is the gold standard surgical technique&#xD;
      allowing to cure this pathology. In this study, investigators are using a new endoluminal&#xD;
      technique of myotomy, innovative and less invasive, called POEM (PerOral Endoscopic Myotomy).&#xD;
      This technique does not require any cutaneous incision.&#xD;
&#xD;
      Mini-invasive surgery is more and more associated to endoscopy. The practice was initiated by&#xD;
      the accession of natural orifice transluminal endoscopic surgery (NOTES). In this context,&#xD;
      the introduction of the POEM technique seems to be an original approach and a natural&#xD;
      evolution to a new generation of surgical endoscopy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">April 2017</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The safety assessment will be based on the reading of all surgical intraoperative complications</measure>
    <time_frame>6 months post surgery</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Esophagus Achalasia</condition>
  <arm_group>
    <arm_group_label>Peroral endoscopic myotomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Peroral endoscopic myotomy</intervention_name>
    <description>Peroral endoscopic myotomy</description>
    <arm_group_label>Peroral endoscopic myotomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Esophagus achalasia&#xD;
&#xD;
          -  Confirmed by esophageal manometry&#xD;
&#xD;
          -  Requiring surgical care&#xD;
&#xD;
          -  No contraindication to general anesthesia&#xD;
&#xD;
          -  BMI under 40 kg/m²&#xD;
&#xD;
          -  Ability to give an informed consent&#xD;
&#xD;
          -  Candidate to elective Heller's myotomy&#xD;
&#xD;
          -  Affiliation to a social security system&#xD;
&#xD;
          -  Signed and informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Advanced esophageal dilatation (sigmoid megaesophagus)&#xD;
&#xD;
          -  Previous mediastinal or esophageal surgery&#xD;
&#xD;
          -  Contraindication to esophagogastroduodenoscopy (EGD)&#xD;
&#xD;
          -  Contraindication to general anesthesia&#xD;
&#xD;
          -  BMI above 40 kg/m²&#xD;
&#xD;
          -  Infectious esophagitis (e.g. candidiasis)&#xD;
&#xD;
          -  Psychiatric context unsuitable with an experimental protocol&#xD;
&#xD;
          -  Allergy to beta-lactam&#xD;
&#xD;
          -  Contraindication to endoscopy (esophageal stenosis, suspicion of digestive&#xD;
             perforation, state of shock, severe anemia, cardiorespiratory failure or severe&#xD;
             metabolic disorders)&#xD;
&#xD;
          -  Contraindication to monitored pneumoperitoneum (cardiorespiratory failure or severe&#xD;
             metabolic disorders)&#xD;
&#xD;
          -  Inability to give an informed consent (emergency situations, misunderstanding…)&#xD;
&#xD;
          -  Patient in custody&#xD;
&#xD;
          -  Patient under guardianship&#xD;
&#xD;
          -  Pregnancy or breastfeeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Silvana PERRETTA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital, Strasbourg, france</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <study_first_submitted>May 9, 2016</study_first_submitted>
  <study_first_submitted_qc>May 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2016</study_first_posted>
  <last_update_submitted>June 30, 2017</last_update_submitted>
  <last_update_submitted_qc>June 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Achalasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

